LINC 2022: BioMimics 3D Stent With Dr Lichtenberg: Safety and Efficacy in Real-World Patients

Подробнее о видео

Watch on Radcliffe Vascular:

Dr Michael Lichtenberg (Vascular Centre Clinic Arnsberg, DE) joins us at LINC 2022 to outline the findings of a the MIMICS-3D trial. This was a study that aimed to analyse the safety, effectiveness and performance of the BioMimics 3D stent in real-world patients for femoropopliteal intervention.

Discussion Points:
1. Outline of the BioMimics 3D Stent Used in This Study
2. Rationale
3. Patient Population and Study Design
4. Key Findings
5. Further Study Needed

Recorded On-site at LINC, Leipzig, 2022.
This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.